GlaxoSmithKline Consumer Healthcare
BSE: 500676 | NSE: GSKCONS | ISIN: INE264A01014 | Food Processing
 |
 |
Quarterly Results of GlaxoSmithKline Consumer Healthcare |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Sep '08 | Dec '08 | Mar '09 | Jun '09 | Sep '09 | ||||||
|
||||||||||
| Sales Turnover | 425.83 | 343.56 | 539.37 | 485.53 | 510.27 | |||||
| Other Income | 23.19 | 14.00 | 25.64 | 6.03 | 6.05 | |||||
| Total Income | 449.02 | 357.56 | 565.01 | 491.56 | 516.32 | |||||
| Total Expenses | 359.43 | 293.15 | 420.71 | 394.13 | 416.48 | |||||
| Operating Profit | 66.40 | 50.41 | 118.66 | 91.40 | 93.79 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 89.59 | 64.41 | 144.30 | 97.43 | 99.84 | |||||
| Interest | 1.40 | 3.03 | 1.32 | 1.05 | 0.99 | |||||
| PBDT | 88.19 | 61.38 | 142.98 | 96.38 | 98.85 | |||||
| Depreciation | 10.44 | 10.66 | 10.61 | 10.53 | 10.50 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 77.75 | 50.72 | 132.37 | 85.85 | 88.35 | |||||
| Tax | 24.72 | 18.14 | 48.48 | 30.66 | 28.33 | |||||
| Net Profit | 53.03 | 32.58 | 83.89 | 55.19 | 60.02 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 12.61 | 7.75 | 19.95 | 13.12 | 14.27 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 42.06 | 42.06 | 42.06 | 42.06 | 42.06 | |||||
| Reserves | -- | -- | -- | -- | -- | |||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore GlaxoSmith Con connections | ||||||||||
| ||||||||||
